Ïðîáëåìíûå ëåêàðñòâà

Ñòðàíèöà: 1 ... 1213141516171819202122 ... 322

28.

Anon., «Call for independent source of French drug information», Scrip, No 1500, 28 Mar 1990, p1.

29.

Anon., «US FDA criticises Praxis’promotion», Scrip, No 1609,19 Apr 1991, pl2; Anon., «FDA censures Bristol-Myers Squibb», Scrip, No 1592, 20 Feb 1991, p11; Anon., «Abbott»s US Hytrin campaign rejected», Scrip, No 1488, 14 Feb 1990, p17; Anon., «FDA criticises Lupron promotion», Scrip, No 1503, 6 Apr 1990, p17.

30.

Anon., «Effectiveness of UK pharma reps», Scrip, No 1596, 6 Mar 1991, p4.

31.

Safavi, K.T. and Hayward, R.A., «Choosing between apples and apples: Physicians’ choices of prescription drugs that have similar side effects and efficacies», Journal of General Internal Medicine, Vol 7, Jan/Feb 1992, pp32-7.

32.

Medawar, C., Power and Dependence, London, Social Audit, 1992; Lacey, R., The Complete Guide to Psychiatric Drugs, London, Ebury Press, 1991; Neill, J.R., «A social history of psychotropic drug advertisements», Social Science and Medicine, Vol 28, No 4, 1989, ððÇÇÇ-8; Toynbee, P., «The patients who get hooked on tranquillisers», Guardian, 25 Nov 1985, p10.

33.

Jackson, D.M. and Soothill, R., Is the Medicine Making You Ill?, North Ryde, Australia, Angus & Robertson, 1989, pp56-7.

34.

Comment made in à ÂÂÑ Radio 4 programme, File on Four, broadcast 11 June 1991

35.

Liss, R.H. and Batchelor, F.R., «Economic evaluations of antibiotic use and resistance - a perspective: report of Task Force 6», Reviews of Infectious Diseases, Vol 9 (Suppl. 3), May-Jun l987, ppS297-312.

36.

O'Reilly, Â., «Drugmakers under attack», Fortune, 29 Jul 1991, pp108-18.

37.

Clark, E., The Want Makers, London, Coronet Books, 1989, p289.

38.

Cunliffe, P.W., «Drugs in the Third World» (letter to the editor), The Listener, 3 Oct 1985.

39.

Randall, Ò., «Kennedy hearings say no more free lunch - or much else - from drug firms», Journal of the American Medical Association, Vol 265, No 4, 23/30 Jan 1991, pp440-2.

40.

Barral, E., Prospective et sante, No 36, Winter 1985/86, pp89-95, cited in WHO, 1988, op cit, pp38-9. See also: Anon., «10 years of NCE discovery analysed», Scrip, No 1062, 23 Dec 1985, pp20-1.

41.

Marsh, P., «Prescribing all the way to the bank», New Scientist, 18 Nov 1989, pp50-5.

42.

Brown, P., «A Caribbean banana lesson for the pharmaceutical industry», Scrip Magazine, No 10, Dec 1992/Jan 1993, pp3-4.

43.

Schwartz, H., «The pharmaceutical companies and their critics», International Health and Development, Mar/Apr 1989, pp24-7.

44.

Leisinger, K.M., Poverty, Sickness and Medicines: an unholy alliance?, Geneva, IFPMA, 1989, p21.

— 17 —
Ñòðàíèöà: 1 ... 1213141516171819202122 ... 322